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Review Article 
Abstract 
Cancers in children, as the major cause of pediatric deaths, account for one percent of all cancers. 
Cancer control program is intended to diminish occurrence, morbidity and mortality and to improve 
the life quality of people with cancer. A key element of any reasonable cancer control program is 
cancer registry. A registry which serves as the backbone for any treatment plan in childhood 
oncology. Given the importance of pediatric cancer, the present paper explores the importance of 
pediatric cancer registry in childhood cancer control. 
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Cancer incidence in children is rare, but it 
constitutes the second major cause of death in 
children younger than 15 years of age after 
accidents (1, 2). With the improved control of 
contagious diseases, today childhood cancer is 
considered as a serious illness in children (3). 
The causes of most pediatric cancers are not 
known, but they may be induced by 
environmental risk factors, exposure to chemical 
substances or common infectious agents, ABO 
blood type and genetics (4). Many genetic 
factors are associated with increased risk of 
childhood cancers, though these factors affect 
only less than 5 percent of all cancers (5, 6). 
Also, cancer incidence rates vary in diverse 
national groups both in a single country or in 
countries with shared national community (7). 
About 75 to 150 people in every one million are 
affected by this disease annually (8). Such 
diversities could be attributed to environmental 
agents, early or delayed exposure to infectious 
disorders and genetic predisposition (7, 9).  
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Childhood cancers are different from adult cancers 
(10). This type of cancers is not limited to a single 
disease and takes a variety of forms and 
pathogenic causes with diverse histopathology 
morphologies, which may affect various parts of 
human body (11-13). According to the 
International Classification of Childhood Cancer 
(ICCC), there are 12 major types of cancers. The 
most common childhood cancers are leukemia and 
lymphoma followed by central nervous system 
(CNS) tumors (14).  
In developing countries, with improved control of 
infectious diseases and current population growth, 
infant mortality rates has dropped, but the 
prevalence of cancer in child is expected to 
increase by 30 percent by 2020 (15). 
Child cancer registries are essential tools to 
monitor and assess the impact of health system 
and cancer treatment (3). Given the role of 
pediatric cancer registry in childhood cancer 
control, this paper sets out to explore its 
importance.  
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Overview of cancer registries 
A cancer control plan is proposed as a public 
health plan formulated to reduce the occurrence 
and cancer-related mortality and to improve the 
quality of life of cancer patients in a particular 
state or country by systematic execution of the 
program based on evidences for early diagnosis, 
prevention, treatment and sedation, and utilization 
of the accessible resources (16). Gathering 
information about occurrence, type and cancer 
status is the first step to manage cancer burden, 
which is conducted by the frame of cancer 
registries (1).  
Cancer registry is an integral part of health 
information which can be utilized to monitor 
cancer types in certain areas and to adjust useful 
cancer control programs (17).  The registries 
allows improved programming of cancer plans, 
providing an effective vehicle for observation and 
assessment of the health system performance (18, 
19). The chief role of cancer registries is 
calculating incidence rates, which enables the 
comparison of different cancer types in various 
demographic groups. Studying the cause and 
methods of preventing cancer is another function 
of theses registries (16). However, there suffer 
from drawbacks such as inaccurate information 
about population, limited diagnostic and treatment 
abilities, cultural barriers, instability of economic 
or political conditions 
and large population movements, which can lead 
to imperfect registration and inaccurate estimation 
of cancer incidence (7). 
The classification of cancer registries are usually 
population- based (PB) or hospital- based (HP). PB 
registries identify all cases of cancers that occur in 
a certain population. HB registries focus on 
patients of a specific type of cancer, which can 
provide detailed information. Since PB registries 
cover a certain population in a geographical 
location, they are considered as the gold standard 
for cancer registry (18). According to reports 
released by the World Health Organization (WHO) 
in 2002 and 2011, PB cancer registries are the 
cornerstone of national cancer plans. PB registries 
collect data from several sources in which cancer 
is probably recognized or treated.  
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These sources include records of diagnostic centers 
such as histopathology or cytopathology 
departments and hospital records. Furthermore, 
death certificates suggest that cancer is a major or 
synergistic cause of death (20).    
HB cancer registries provide an opportunity to start 
a recording process by offering data about the 
clinical epidemiology of cancer. It also allows 
gathering important information about all patients 
referred to hospitals during their disease under 
various treatment conditions. It should be noted 
that HB registry cannot replace the PB registry, but 
this type of registry constitutes the first step for 
organizing a PB cancer registry (18). To set up a 
registry, whether PB or HB, it is vital to identify 
suitable resources, seek assistance from the 
government, policy makers and professionals and 
collect relevant data. Long-term support and 
cooperation are essential to set up a registry (18). 
Some of the key criteria of registry records can be 
categorized into identification and demographic 
information (including sex, date and place of birth 
and address), diagnostic information (including 
date of the first visit, diagnostic tests, date of 
diagnosis, primary site, histopathological type, size 
and stage of tumor), the first course of treatment 
(including presence/absence of an open surgery  
resection, chemotherapy and radiation) and follow 
up information (including 
vital status and date of last follow-up) (16, 18, 21). 
The role of cancer registries in pediatric 
oncology 
Cancer in people below the age of 20 is relatively 
rare, and its occurrence can raise a series of 
psychological, medical, societal and ethical 
concerns. Furthermore, particular treatment 
methods should be applied for these cancers (22).   
About 200,000 children and teenagers are 
diagnosed with cancer worldwide every year, of 
whom 80% live in low-income and middle-income 
countries (LMICs), which account for nearly 90% 
of cancer-induced deaths in childhood (7).  
Furthermore, due to the effects of cancer itself or 
its treatment methods, this type of cancers is 
associated with long-term inability (7).    
Epidemiology plays a major role in unraveling 
pediatric cancer causes (23).  
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). Updating information about pediatric cancer 
incidence is pivotal to epidemiologic research, 
disease supervision and establishment of a 
foundation for service delivery programming (24).  
Child cancer registries for specific populations are 
essential to monitor and evaluate the efficacy of 
health systems and cancer treatment and provide 
records on time-corrective activities (3). They 
represent the first step in managing cancer burden 
to gather information about type, frequency and 
sites of cancer incidence (4). 
However, setting up a childhood cancer registry 
for a population group, particularly in limited- 
recourses settings, is a challenge, but it is possible 
to set up a high-quality childhood national cancer 
registry due to the low rate of child cancer cases, 
particularly in countries where child cancer 
treatment is focused in certain hospitals (3). 
The various spectrums of child cancers, relative 
scarcity of childhood cancers and their 
classification based on histology, as compared 
with site-specific classifications, to evaluate 
cancer incidence and death in adults, are among 
factors that distinguish childhood cancer registries 
from adult registries (7). Furthermore, despite a 
number of PB cancer registries, scant attention has 
been paid to gathering data about pediatric 
cancers. As these registries demonstrate a small 
portion of all cancers, more sources of information 
might be requires and final statistics should be 
taken into account for precise quality control, 
considering their sensitivity to inaccurate or 
missing data (7).  In view of the costs, problems 
and uncertainties associated with true PB cancer 
registries, HB registries constitute an accurate 
dataset for childhood cancer, as well as the first 
step to possible PB evaluation of cancer incidence 
rate (7).   Overview of pediatric cancer registries in the word  
Childhood Cancer International (CCI), formerly 
known as the International Confederation of 
Childhood Cancer Parent Organizations, which 
was established in 1994, acts as a worldwide 
umbrella organization that covers paediatric 
cancer grassroots and national parent 
organizations. CCI has proposed the  reasons why 
childhood cancer should be a global child health 
priority, which include: 
Statistics does not tell the whole story: The 
estimation of total cases of new paediatric cancer 
is 175,000-250,000 each year, which is a 
considerable underestimate. It could be due to the 
deficiency of most cancer registries in LMICs, 
prevalent misdiagnosis and under diagnosis and/or 
under-registration of LMIC children with cancer. 
It is estimated that about 90% of children with 
cancer live in developing countries (LMIC).  
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 Paediatric cancer does not have border:  
Child deaths due to infectious diseases has 
dropped dramatically worldwide, but the 
mortality rate of paediatric cancer is on 
rise. An increasing share of child mortality 
in both developed countries and LMIC is 
related to non- communicable diseases 
(NCD), particularly child cancer. Most 
public health practitioners are concerned 
about this increasing rate. 
Paediatric cancer is treatable, but there is 
vast difference between countries and 
continents in terms of survival rates: At 
the present, more than 70% of paediatric 
cancers are treatable using novel 
therapeutic methods. However, the 
survival rate depends on the type of cancer 
and factors such as medical culture, health 
system of a country and socioeconomic 
situation. In LMICs, the health care 
systems suffer from serious limitations and 
problems and survival rate of pediatric 
patients in these countries is 10-20% (that 
is, only 1-2 child out of 10 diagnosed with 
and treated for cancer will survive) while 
this rate is 80 –90% in HICs (that is, only 
one or two child diagnosed with and 
treated for cancer will die). 
Chid are our future and they serve to live: 
With the death of each child, families, 
communities and nations lose a wealth of 
their potentials and talents. Furthermore, 
many survivors often experience 
depression and anxiety, which can have a 
huge bearing on their well-being.  
No family should lose its assets and go 
bankrupt when a child develops cancer  
Access to best possible care for children 
with cancer is their right as a human 
not a privilege: children with cancer  
deserve to live life to the full. The future of 
children with cancer should not rest solely 
on the shoulder of parents and friends who 
have lost their loved kids, or the kindness 
of strangers who feel their pain. The 
leaders of societies should be held 
accountable and serious and decisive 
measures should be taken to meet the 
demands of children with cancer, survivors 
and their families.  
This type of cancer is relatively rare so that 
cancer incidence in children (under 15 
years of age) in industrialized countries is 
less than 1% of all cancers. In developed 
countries, despite considerable therapeutic 
advancement, cancer is the second most 
common cause of death in children (7).   
  It is difficult to identify sources and 
determinants of pediatric cancer despite 
growing information acquired about child 
cancer incidence during the past decades 
(25).  Chow et al. conducted a population-
based case control study on race-related 
cancer incidence among children in five  
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states of America. The results demonstrated that 
whites, black and mixed white/black children 
were different in this regard, which  could be 
attributed to ethnic, socioeconomic and genetic 
factors (7).  In 1971, the National Pediatric Cancer 
Registry was established by Hungarian Pediatric 
Oncology Network.  Data recorded in this registry 
is based on epidemiology, treatment status and 
follow-up of child cancers. An Internet- based 
child cancer registration and connection system 
was introduced by National Pediatric Cancer 
Registry in 2010 (8). In Europe, over 200 child 
cancer registries for different stages of 
development have been set up for data collection 
(26).  The number of these registries has been on 
rise even in areas where common cancer registries 
are already in place (26). The establishment of 
Pediatric Cancer Registry indicates a step forward 
in the realm of pediatric cancer to evaluate the 
effectiveness of childhood cancer treatments and 
maximize utilization of medical assets (8).     
Unfortunately, in LMICs, the epidemiology of 
childhood cancer is not taken seriously (18). In 
these countries, pediatric cancer is considered as a 
"candidate cancer with controlling cancer manage 
opportunities" the results of which offer an ideal 
analysis of defense and function (27). However, 
research on causes and treatment of cancer is 
limited, which could be due to scarcity of 
resources and training, financial limitations, lower 
priority of cancer control program, improper 
infrastructure and limited experience (18, 28). In 
these countries, the lack of high-quality PB cancer 
registries limits access to data on the 
epidemiology of childhood cancer (7).  The 
establishment of a cancer registry in these 
countries poses a major challenge due to problems 
that must be addressed to enhance the quality and 
exhaustiveness of information (18).  
In developing countries, due to their particular 
socioeconomic situation, the convergence of both 
PB and HB provides an apt opportunity. In this 
context, PB and HB can be established to gather 
various data on cancer, but their cooperation will 
surely yield positive results for present and future 
patients with cancer (18). 
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In general, cancer registries are crucial for monitoring and planning cancer to identify public health 
preferences. Data collection and interpretation along with operationalization of results are among the 
goals of cancer registries.  They are used to ensure cancer surveillance, thereby laying the ground for 
further investigation and policy decisions. Setting up cancer registries for children is essential to 
monitor and assess the impact of health system and cancer treatment. Such information can be 
obtained by fostering cooperation between low-income and high-income countries. The effect of this 
strategy on cancer outcomes is providing resources and intellectual skill to report cancer prevalence in  
LMICs and formulate universal plans. However, given that the incidence of pediatric cancer is 
unknown in many LMICs, greater attention should be paid to the development of pediatric cancer 
registries in LMICs.  
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